Adrienne Lahti

Adrienne Lahti
Professor / Chairperson

Professor (P), Psychiatry - Behavioral Neurobiology , Psychiatry 2006 -
Scientist (C), Civitan International Research Center , Academic Joint Departments 2006 -
Scientist (C), Center for Dev Func Imaging (CDFI) (Retired Org) , Vision Sciences (Retired Org) 2007 -
Scientist (C), Comprehensive Neuroscience Center , General Clinical Research Center 2008 -
Scientist (C), Center for Clinical and Translational Science (CCTS) , General Clinical Research Center 2009 -
Professor (S), Psychology , College of Arts and Sciences 2013 -
Senior Scientist (C), Vision Science Research Center (Retired Org) , Vision Sciences (Retired Org) 2013 -
Investigator (C), Evelyn F. McKnight Brain Institute , Neurology 2017 -
Director of Comprehensive Neuroscience Center, Comprehensive Neuroscience Center , General Clinical Research Center 2020 -
Interim Department Chairperson, Psychiatry , School of Medicine 2020 -

Selected Publications

Academic Article

Year	Title	Altmetric
2019	A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia. Schizophrenia Research. 210:239-244. 2019
2019	Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia. Schizophrenia Research. 204:262-270. 2019
2019	7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. Schizophrenia Bulletin. 45:180-189. 2019
2019	Examining resting-state functional connectivity in first-episode schizophrenia with 7T fMRI and MEG. NeuroImage: Clinical. 24. 2019
2018	Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication. npj Schizophrenia. 4. 2018
2018	Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients. Psychiatry Research: Neuroimaging. 281:101-106. 2018
2018	Four-way multimodal fusion of 7 T imaging data using an mCCA+jICA model in first-episode schizophrenia. Human Brain Mapping. 39:1475-1488. 2018
2018	Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 3:231-238. 2018
2018	Paving the way for targeted drug development in schizophrenia. JAMA Psychiatry. 75:19-20. 2018
2017	Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder- A systematic review of the magnetic resonance neuroimaging literature. npj Schizophrenia. 3. 2017
2017	Glutamate/glutamine concentrations in the dorsal anterior cingulate vary with Post-Traumatic Stress Disorder symptoms. Journal of Psychiatric Research. 91:169-176. 2017
2017	Ketamine modulates hippocampal neurochemistry and functional connectivity: A combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Molecular Psychiatry. 22:562-569. 2017
2017	The effect of saccadic eye movements on the sensor-level magnetoencephalogram 2017
2017	Risperidone effects on brain dynamic connectivity-A prospective resting-state fMRI study in Schizophrenia. Frontiers in Psychiatry. 8. 2017
2017	Predictors of medication adherence and smoking cessation among smokers under community corrections supervision. Addictive Behaviors. 65:111-117. 2017
2016	A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia. Schizophrenia Research. 170:341-350. 2016
2016	Aberrant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: A longitudinal resting state functional mri study. Schizophrenia Bulletin. 42:1046-1055. 2016
2015	Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication. Human Brain Mapping. 36:1442-1457. 2015
2014	Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology. 39:1020-1030. 2014
2014	Delay discounting and task performance consistency in patients with schizophrenia. Psychiatry Research. 215:286-293. 2014
2014	Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. Psychiatry Research: Neuroimaging. 221:6-12. 2014
2014	A Full-Brain, Bootstrapped Analysis of Diffusion Tensor Imaging Robustly Differentiates Parkinson Disease from Healthy Controls. Neuroinformatics. 13:7-18. 2014
2014	Expectancies for the effectiveness of different tobacco interventions account for racial and gender differences in motivation to quit and abstinence self-efficacy. Nicotine and Tobacco Research. 16. 2014
2014	Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia 2014
2014	How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Nicotine and Tobacco Research. 16:1348-1355. 2014
2014	Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: Preliminary findings. Frontiers in Pharmacology. 5 JUL. 2014
2014	Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: Relationship to treatment and treatment response. Neuropsychopharmacology. 39:2095-2103. 2014
2014	Vergence eye movements in patients with schizophrenia. Vision Research. 102:64-70. 2014
2013	Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. JAMA Psychiatry. 70:1294-1302. 2013
2011	Aberrant visual circuitry associated with normal spatial match-to-sample accuracy in schizophrenia. Psychiatry Research: Neuroimaging. 193:138-143. 2011
2011	Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia. Neuropsychopharmacology. 36:1779-1780. 2011
2011	Mitochondria in the striatum of subjects with schizophrenia: Relationship to treatment response 2011
2010	Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biological Psychiatry. 68:625-633. 2010
2010	Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology. 35:632-640. 2010
2009	Modulation of limbic circuitry predicts treatment response to antipsychotic medication: A functional imaging study in schizophrenia. Neuropsychopharmacology. 34:2675-2690. 2009
2009	Dopaminergic synapses in the caudate of subjects with schizophrenia: Relationship to treatment response 2009
2006	Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology. 31:221-230. 2006
2005	Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology. 30:2275-2282. 2005
2005	The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology. 183:265-274. 2005
2005	Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Research: Neuroimaging. 139:19-30. 2005
2004	Parametric study of accuracy and response time in schizophrenic persons making visual or auditory discriminations. Psychiatry Research. 127:207-216. 2004
2000	Ketamine effects on eye movements. Neuropsychopharmacology. 23:645-653. 2000
2000	The limbic cortex in schizophrenia: Focus on the anterior cingulate. Brain Research Reviews. 31:364-370. 2000
2000	Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. American Journal of Psychiatry. 157:1634-1645. 2000
2000	Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry. 57:533-538. 2000
1998	Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia. Journal of Neural Transmission. 105:719-734. 1998
1998	Cerebral blood flow relationships associated with a difficult tone recognition task in trained normal volunteers. Cerebral Cortex. 8:534-542. 1998
1998	The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia. Schizophrenia Research. 31:141-150. 1998
1998	Antipsychotic properties of the partial dopamine agonist (-)-3-(3- hydroxyphenyl)-N-n-propylpiperidine (preclamol) in schizophrenia. Biological Psychiatry. 43:2-11. 1998
1998	Association between eye tracking disorder in schizophrenia and poor sensory integration. American Journal of Psychiatry. 155:1352-1357. 1998
1997	Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome. Biological Psychiatry. 42:781-796. 1997